Loading...
OTCM
AVVH
Market cap1mUSD
Jul 09, Last price  
0.00USD
1D
-42.11%
1Q
-65.52%
IPO
1,000.00%
Name

avVaa World Health Care Products Inc

Chart & Performance

D1W1MN
OTCM:AVVH chart
P/E
P/S
228.72
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-6.94%
Revenues
5k
00009,40913,02118,65795,57702,00004,650
Net income
-39k
L-8.49%
-267,532-252,21537,589-819,608-2,230,958-3,145,775-4,035,067-4,470,747-28,974-75,257-42,751-39,123
CFO
-246k
L-81.67%
-136,923-159,225-92,875-415,892-918,838-1,194,594-1,309,104-1,342,252-246,008

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

AVVAA World Health Care Products, Inc. operates as a global biotechnology firm, specializing in natural and therapeutic personal care solutions. Its primary endeavor involves the development, manufacturing, and mass-market distribution of the over-the-counter Neuroskin product line. These treatments are formulated to address various skin irregularities and promote the natural clarity and texture of healthy skin, reaching consumers through conventional food and drug channels. Beyond its own brands, AVVAA also possesses distribution rights for a range of patented European skincare items. These scientifically-backed formulations target the symptoms of persistent dermatological conditions such as eczema, psoriasis, and acne. Diversifying its portfolio, the company extends its natural care offerings to animals, providing grooming treatments for a variety of pets including dogs, cats, and horses. Established in 1998 and headquartered in Richmond, Virginia, AVVAA has been a subsidiary of Gold Quest Capital, Inc. since June 23, 2021.
IPO date
Feb 23, 2001
Employees
5
Domiciled in
CA
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFY
2025‑052024‑052023‑052022‑05
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT